Ovary removal reduces risk of death from any cause in people with BRCA mutations
Full article:

People who test positive for an inherited BRCA1 or BRCA2 mutation can reduce their risk of ovarian cancer by having both ovaries and fallopian tubes removed. A study published in 2024 found an added benefit of this surgery – a lower risk of death from any cause by age 75. (Posted 5/23/24)

Questions To Ask Your Health Care Provider

Open Clinical Trials

The following are studies looking at level of risk or risk-management for people with inherited BRCA1 or BRCA2 mutations. Check study listings or contact the study team to see if you are eligible. 

Multiple cancers

Breast cancer

Prostate cancer

Ovarian cancer

Pancreatic cancer

Additional risk-management clinical trials for people with inherited mutations may be found here.


FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.